A man from Brighton has spoken out after the NHS agreed to offer a life-extending drug to more men with prostate cancer. Currently only those with prostate cancer that has spread can get abiraterone ...

Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...

Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...

For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after ...

Thousands of men with prostate cancer will be given a life-extending drug on the NHS, following a three-year battle to expand ...

Ghanaian-born researcher David U. Mualen, a PhD candidate in Biomedical Engineering in the United States, is gaining international recognition for research that is reshaping how modern medicines are ...

A Sri Lankan-born scientist has made waves in the global medical community with groundbreaking research that could ...

UF Health Cancer Institute scientists found a bacterial compound that may double lung cancer treatment effectiveness in mice.

In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...

Presenters shared their personal highlights of attending ASCO GI 2026. The 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium showcased not only transformative ...